We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00805376
Recruitment Status : Completed
First Posted : December 9, 2008
Last Update Posted : January 31, 2018
Information provided by (Responsible Party):
DNAtrix, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2015
  Study Completion Date : February 2015